Calcification resistance of procyanidin-treated decellularized porcine aortic valves in vivo

Heart Surgery Forum

Volumn 12, Issue 1, 2009, Pages

  Liu, Yang ^a   Liu, Weiyong ^a   Sun, Guocheng ^a   Wei, Xufeng ^a   Yi, Dinghua ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EOSIN; GLUTARALDEHYDE; HEMATOXYLIN; PROCYANIDIN; ANTIOXIDANT; BIFLAVONOID; CATECHIN; PROANTHOCYANIDIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA VALVE; AORTA VALVE DISEASE; ARTICLE; BIOPROSTHESIS; CALCIFICATION; CONTROLLED STUDY; CROSS LINKING; EXTRACELLULAR MATRIX; HEART PROTECTION; HISTOLOGY; HISTOPATHOLOGY; IN VIVO STUDY; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROCYANIDIN DECELLULARIZED AORTA VALVE; RAT; ROENTGEN SPECTROSCOPY; SCANNING ELECTRON MICROSCOPY; SWINE; TENSILE STRENGTH; TISSUE FIXATION; XENOGRAFT; ANIMAL; AORTA VALVE STENOSIS; CALCINOSIS; CELL FREE SYSTEM; DRUG EFFECT; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; METHODOLOGY; TRANSPLANTATION; TREATMENT OUTCOME;

ANIMALS; ANTIOXIDANTS; AORTIC VALVE; AORTIC VALVE STENOSIS; BIFLAVONOIDS; BIOPROSTHESIS; CALCINOSIS; CATECHIN; CELL-FREE SYSTEM; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; MODELS, ANIMAL; PROANTHOCYANIDINS; RATS; TREATMENT OUTCOME;

EID: 66649125059     PISSN: 10983511     EISSN: 15226662     Source Type: Journal    
DOI: 10.1532/HSF98.20081103     Document Type: Article

References (39)

1. Aldini G, Carini M, Piccoli A, Rossoni G, Facino RM. 2003. Procyanidins from grape seeds protect endothelial cells from peroxynitrite damage and enhance endothelium-dependent relaxation in human artery: new evidence for cardio-protection. Life Sci 73:2883-98.
2. Bechtel JF, Muller-Steinhardt M, Schmidtke C, Bruswik A, Stierle U, Sievers HH. 2003. Evaluation of the decellularized pulmonary valve homograft (SynerGraft). J Heart Valve Dis 12:734-9.
3. Bernacca GM, Tobasnick G, Wheatley DJ. 1994. Dynamic in-vitro calcification of porcine aortic valves. J Heart Valve Dis 3:684-7.
4. Broyn T, Christensen O, Fossdal JE, Kordt KF, Kroese A, Myhre HO. 1986. Early complications with a new bovine arterial graft (Solcograft-P). Acta Chir Scand 152:263-6.
5. Cebotari S, Mertsching H, Kallenbach K, et al. 2002. Construction of autologous human heart valves based on an acellular allograft matrix. Circulation 106(12 suppl 1):I-63-8.
6. Courtman DW, Pereira CA, Kashef V, McComb D, Lee JM, Wilson GJ. 1994. Development of a pericardial acellular matrix biomaterial: biochemical and mechanical effects of cell extraction. J Biomed Mater Res 28:655-66.
7. Dongmo AB, Kamanyi A, Anchang MS, et al. 2001. Anti-inflammatory and analgesic properties of the stem bark extracts of Erythrophleum suaveolens (Caesalpiniaceae) Guillemin & Perrottet. J Ethnopharmacol 77:137-41.
8. Ferrans VJ, Milei J, Ishihara T, Storino R. 1991. Structural changes in implanted cardiac valvular bioprostheses constructed of glycerol-treated human dura mater. Eur J Cardiothorac Surg 5:144-54.
9. Girardot JM, Girardot MN. 1996. Amide cross-linking: an alternative to glutaraldehyde fixation. J Heart Valve Dis 5:518-25.
10. Han B, Jaurequi J, Tang WB, Nimni ME. 2003. Proanthocyanidin: a natural crosslinking reagent for stabilizing collagen matrices. J Biomed Mater Res 65:118-24.
11. Jayaprakasha GK, Selvi T, Sakariah KK. 2003. Antibacterial and antioxidant ] activities of grape (Vitis vinifera) seed extracts. Food Res Int 36:117-22.
12. Levy RJ, Schoen RJ, Levy JT, Nelson AC, Howard SL, Oshry LJ. 1983. Biologic determinants of dystrophic calcification and osteocalcin deposition in glutaraldehyde-preserved porcine aortic valve leaflets implanted subcutaneously in rats. Am J Pathol 113:143-55.
13. Mako WJ, Vesely I. 1997. In-vivo and in-vitro models of calcification in porcine aortic valve cusps. J Heart Valve Dis 6:316-23.
14. Naimark WA, Pereira CA, Tsang K, Lee JM. 1995. HMDC crosslinking of bovine pericardial tissue: a potential role of the solvent environment in the design of bioprosthetic materials. J Mater Sci Mater Med 6:235-41.
15. Nemes A, Acsady G, Fraefel W, et al. 1985. Application of a vascular graft material (Solcograft-P) in experimental surgery. Biomaterials 6:303-11.
16. Ogino Y, Osada K, Nakamura S, Ohta Y, Kanda T, Sugano M. 2007. Absorption of dietary cholesterol oxidation products and their downstream metabolic effects are reduced by dietary apple polyphenols. Lipids 42:151-61.
17. Packer L, Rimbach G, Virgili F. 1999. Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus Maritima) bark, pycnogenol. Free Radic Biol Med 27:704-24.
18. Park KD, Yun JY, Han DK, et al. 1994. Chemical modification of implantable biologic tissue for anti-calcification. ASAIO J 40:M377-82.
19. Pereira CA, Lee JM, Haberer SA. 1990. Effect of alternative crosslinking methods on the low strain rate viscoelastic properties of bovine pericardial bioprosthetic material. J Biomed Mater Res 24:345-61.
20. Pettenazzo E, Deiwick M, Thiene G, et al. 2001. Dynamic in vitro calcification of bioprosthetic porcine valves: evidence of apatite crystallization. J Thorac Cardiovasc Surg 121:500-9.
21. Plumb GW, De Pascual-Teresa S, Santos-Buelga C, Cheynier V, Williamson G. 1998. Antioxidant properties of catechins and proanthocyanidins: effect of polymerisation, galloylation and glycosylation. Free Radic Res 29:351-8.
22. Rapoport HS, Connolly JM, Fulmer J, et al. 2007. Mechanisms of the in vivo inhibition of calcification of bioprosthetic porcine aortic valve cusps and aortic wall with triglycidylamine/mercapto bisphosphonate. Biomaterials 28:690-9.
23. Schinke T, McKee MD, Karsenty G. 1999. Extracellular matrix calcification: where is the action? Nat Genet 21:150-1.
24. Schmitz-Rixen T, Megerman J, Anderson JM, et al. 1991. Longterm study of a compliant biological vascular graft. Eur J Vasc Surg 5:149-58.
25. Schoen FJ. 1999. Future directions in tissue heart valves: impact of recent insights from biology and pathology. J Heart Valve Dis 8:350-8.
26. Schoen FJ, Levy RJ. 1999. Tissue heart valves: current challenges and future research perspectives. J Biomed Mater Res 47:439-65.
27. Schoen FJ, Levy RJ. 2005. Calcification of tissue heart valve substitutes: progress toward understanding and prevention. Ann Thorac Surg 79:1072-80.
28. Schoen FJ, Levy RJ, Nelson AC, Bernhard WF, Nashef A, Hawley M. 1985. Onset and progression of experimental bioprosthetic heart valve calcification. Lab Invest 52:523-32.
29. Schoen FJ, Tsao JW, Levy RJ. 1986. Calcification of bovine pericardium used in cardiac valve bioprostheses. Implications for mechanisms of bioprosthetic tissue mineralization. Am J Pathol 123:134-45.
30. Schmidt CE, Baier JM. 2000. Acellular vascular tissues: natural biomaterials for tissue repair and tissue engineering. Biomaterials 21:2215-31.
31. Shahat AA, Cos P, De Bruyne T, et al. 2002. Antiviral and antioxidant activity of flavonoids and proanthocyanidins from Crataegus sinaica. Planta Med 68:539-41.
32. Simionescu DT. 2004. Prevention of calcification in bioprosthetic heart valves: challenges and perspectives. Expert Opin Biol Ther 4:1971-85.
33. Simon P, Kasimir MT, Seebacher G. 2003. Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur J Cardiothorac Surg 23:1002-6.
34. Sugiyama H, Akazome Y, Shoji T, et al. 2007. Oligomeric procyanidins in apple polyphenol are main active components for inhibition of pancreatic lipase and triglyceride absorption. J Agric Food Chem 55:4604-9.
35. Valente M, Bortolotti U, Thiene G. 1985. Ultrastructural substrates of dystrophic calcification in porcine bioprosthetic valve failure. Am J Pathol 119:12-21.
36. Wilson GJ, Courtman DW, Klement P, Lee JM, Yeger H. 1995. Acellular matrix: a biomaterials approach for coronary artery and heart valve replacement. Ann Thorac Surg 60(2 Suppl):S353-8.
37. Zhai W, Chang J, Lin K, Wang J, Zhao Q, Sun X. 2006. Crosslinking of decellularized porcine heart valve matrix by procyanidins. Biomaterials 27:3684-90.
38. Zhao J, Wang J, Chen Y, Agarwal R. 1999. Anti-tumor-promoting activity of a polyphenolic fraction isolated from grape seeds in the mouse skin two-stage initiation-promotion protocol and identification of procyanidin B5-3′-gallate as the most effective antioxidant constituent. Carcinogenesis 20:1737-45.
39. Zilla P, Brink J, Human P, Bezuidenhout D. 2008. Prosthetic heart valves: catering for the few. Biomaterials 29:385-406.